EBCOG P1 – 3 month May 2022 – PRECONCEPTION CARE and ANTENATAL CARE – Day 4 EBCOG P1 - 3 month May 2022 - PRECONCEPTION CARE and ANTENATAL CARE - Day 4 Name A. lntracardiac echogenic focusB. Ventriculomegaly C. Increased nuchal fold D. Echogenic bowel E. Mild hydronephrosis F. Aberrant right subclavian artery G. Absent or hypoplastic nasal H. Karyotyping I. CVS/amniocentesisJ. PAPPA K. HCGL. InhibinM. Cell free fetal DNAFor each description below choose the single most appropriate answer from the above list of options. Each option may be used once, more than once or not at all.1 . Which soft marker has highest positive likelihood ratio for down syndrome? Please select your answer A. lntracardiac echogenic focus B. Ventriculomegaly C. Increased nuchal fold D. Echogenic bowel E. Mild hydronephrosis F. Aberrant right subclavian artery G. Absent or hypoplastic nasal H. Karyotyping I. CVS/amniocentesis J. PAPPA K. HCG L. Inhibin M. Cell free fetal DNA 2 . Presence of this marker is a major risk factor for SGA ? Please select your answer A. lntracardiac echogenic focus B. Ventriculomegaly C. Increased nuchal fold D. Echogenic bowel E. Mild hydronephrosis F. Aberrant right subclavian artery G. Absent or hypoplastic nasal H. Karyotyping I. CVS/amniocentesis J. PAPPA K. HCG L. Inhibin M. Cell free fetal DNA 3 . Best screening method for Downs with highest sensitivity? Please select your answer A. lntracardiac echogenic focus B. Ventriculomegaly C. Increased nuchal fold D. Echogenic bowel E. Mild hydronephrosis F. Aberrant right subclavian artery G. Absent or hypoplastic nasal H. Karyotyping I. CVS/amniocentesis J. PAPPA K. HCG L. Inhibin M. Cell free fetal DNA 4 . Best option to do if ultrasound examination in the first or second trimester demonstrates major anatomical defects ? Please select your answer A. lntracardiac echogenic focus B. Ventriculomegaly C. Increased nuchal fold D. Echogenic bowel E. Mild hydronephrosis F. Aberrant right subclavian artery G. Absent or hypoplastic nasal H. Karyotyping I. CVS/amniocentesis J. PAPPA K. HCG L. Inhibin M. Cell free fetal DNA 5.The performance of this marker screening, it is better to take a blood sample at 9-10 weeks rather than at 13 weeks? Please select your answer A. lntracardiac echogenic focus B. Ventriculomegaly C. Increased nuchal fold D. Echogenic bowel E. Mild hydronephrosis F. Aberrant right subclavian artery G. Absent or hypoplastic nasal H. Karyotyping I. CVS/amniocentesis J. PAPPA K. HCG L. Inhibin M. Cell free fetal DNA A. Maternal historyB. Mean arterial pressureC. Sflt/plgf ratioD. First trimester Uterine artery PIE. ASPRE trial F. GRID trial G. MAGPIE trial H. History + biophysical + biochemical I. AFP , PAPPA , PLGFJ. SFLT , PLPFK. SFLT , PAPPA For each description below choose the single most appropriate answer from the above list of options. Each option may be used once, more than once or not at all.6.Best method to predict Preeclampsia ? Please select your answer A. Maternal history B. Mean arterial pressure C. Sflt/plgf ratio D. First trimester Uterine artery PI E. ASPRE trial F. GRID trial G. MAGPIE trial H. History + biophysical + biochemical I. AFP , PAPPA , PLGF J. SFLT , PLPF K. SFLT , PAPPA 7.This method detects 48% of women who will develop early PE (7.9% false positive rate), 39.2% of cases of early fetal growth restriction ? Please select your answer A. Maternal history B. Mean arterial pressure C. Sflt/plgf ratio D. First trimester Uterine artery PI E. ASPRE trial F. GRID trial G. MAGPIE trial H. History + biophysical + biochemical I. AFP , PAPPA , PLGF J. SFLT , PLPF K. SFLT , PAPPA 8.This test evaluated evaluated between 20 and 35 weeks' gestation allows pre-eclampsia to be excluded? Please select your answer A. Maternal history B. Mean arterial pressure C. Sflt/plgf ratio D. First trimester Uterine artery PI E. ASPRE trial F. GRID trial G. MAGPIE trial H. History + biophysical + biochemical I. AFP , PAPPA , PLGF J. SFLT , PLPF K. SFLT , PAPPA 9.The following markers are lower than normal in PE ? Please select your answer A. Maternal history B. Mean arterial pressure C. Sflt/plgf ratio D. First trimester Uterine artery PI E. ASPRE trial F. GRID trial G. MAGPIE trial H. History + biophysical + biochemical I. AFP , PAPPA , PLGF j. SFLT , PLPF K. SFLT , PAPPA 10.The famous trial to prevent early onset PE? Please select your answer A. Maternal history B. Mean arterial pressure C. Sflt/plgf ratio D. First trimester Uterine artery PI E. ASPRE trial F. GRID trial G. MAGPIE trial H. History + biophysical + biochemical I. AFP , PAPPA , PLGF J. SFLT , PLPF K. SFLT , PAPPA Time's up monisha2022-04-06T09:38:26+00:00